News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BOHLIN GAREN G
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 05/19/2023 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 9,792 shares
@ $0 |
|
| 05/23/2022 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 14,035 shares
@ $0 |
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2021 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Bought 4,000 shares
@ $7.82, valued at
$31.3k
|
|
| 05/26/2020 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 16,400 options to buy
@ $19.11, valued at
$313.4k
|
|
| 05/22/2020 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 4,047 shares
@ $0
Granted 8,095 options to buy
@ $22.05, valued at
$178.5k
|
|
| 06/11/2019 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 16,500 options to buy
@ $0.77, valued at
$12.7k
|
|
| 06/07/2019 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.43, valued at
$135.8k
|
|
| 04/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2018 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $18.8, valued at
$319.6k
|
|
| 06/11/2018 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 12,700 options to buy
@ $2.5, valued at
$31.8k
|
|
| 06/01/2018 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 12,500 options to buy
@ $3.68, valued at
$46k
|
|
| 05/29/2018 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 2,253 shares
@ $0
Granted 4,506 options to buy
@ $24.95, valued at
$112.4k
|
|
| 11/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2017 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 6,666 options to buy
@ $1.3, valued at
$8.7k
|
|
| 06/16/2017 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.18, valued at
$156.1k
|
|
| 06/01/2017 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 12,500 options to buy
@ $6.89, valued at
$86.1k
|
|
| 05/25/2017 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 19,853 options to buy
@ $9.33, valued at
$185.2k
|
|
| 06/17/2016 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc. |
| 06/14/2016 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 6,666 options to buy
@ $5.9, valued at
$39.3k
|
|
| 06/13/2016 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 8,700 options to buy
@ $16.49, valued at
$143.5k
|
|
| 06/10/2016 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $4.27, valued at
$42.7k
|
|
| 06/11/2015 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $42.26, valued at
$422.6k
|
|
| 06/03/2015 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 6,666 options to buy
@ $17.59, valued at
$117.3k
|
|
| 05/26/2015 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 10,000 options to buy
@ $26.15, valued at
$261.5k
|
|
| 07/09/2014 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 10,000 options to buy
@ $36.04, valued at
$360.4k
|
|
| 06/16/2014 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $11.26, valued at
$112.6k
|
|
| 03/27/2013 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $7.07, valued at
$141.4k
|
|
| 01/06/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|